ABSTRACT There is evidence that collaborations between hospitals and physicians in particular regions of the country have led to improvements in the quality of care. Even so, there have not been many of these collaborations. We review one, the Michigan regional collaborative improvement program, which was paid for by a large private insurer, has yielded improvements for a range of clinical conditions, and has reduced costs in several important areas. In general and vascular surgery alone, complications from surgery dropped almost 2.5 percent among participating Michigan hospitals-a change that translates into 2,500 fewer Michigan patients with surgical complications each year. Estimated annual savings from this one collaborative are approximately $20 million, far exceeding the cost of administering the program. Regional collaborative improvement programs should become increasingly attractive to hospitals and physicians, as well as to national policy makers, as they seek to improve health care quality and reduce costs.
T he need to improve quality of care in US hospitals is widely recog nized. Potentially avoidable ad verse events are common among hospitalized patients, and wide variation in hospital performance outcomes sug gests that there is ample room for improve ment. [1] [2] [3] [4] The business case for improving hospi tal quality is also apparent. In surgery, for example, the true cost associated with treating complications exceeds $10,000 per patient, the large majority of which is passed on to payers and purchasers. 5 Additional payments for com plicated hospital stays (outlier payments), un planned readmissions, and care following dis charge for patients with complications account for approximately 20 percent of the total costs associated with many inpatient procedures, ac cording to national Medicare data. 6 
Background On Hospital Quality Improvement
Despite increasing attention from payers, policy makers, and professional organizations, largescale efforts to improve hospital quality have had little effect on patient outcomes. Public report ing of performance data may motivate hospitals to improve. 7 However, there remain doubts that programs such as the Centers for Medicare and Medicaid Services' Hospital Compare website or the Leapfrog Group's selective referral initiative will be successful in redirecting large numbers of patients to hospitals that have demonstrated superior results. [8] [9] [10] Simply put, it hasn't been demonstrated that patients will actually stop going to hospitals that achieve poor results and start going to hospitals that achieve far bet ter ones. Even if practical barriers to changing these referral patterns could be addressedsuch as efficient transfer of patients' medical records-these initiatives are limited by a lack of good data and measures for identifying truly superior hospitals.
Varied Approaches In addition to not paying for so-called never events, such as surgical pro cedures on the wrong site or when foreign ob jects are left inside a patient after surgery, both public and private insurers have implemented pay-for-performance programs aimed at increas ing the use of specific, evidence-based practices. An example is ensuring that a patient is taking a beta-blocker when discharged from the hospital after a myocardial infarction, or heart attack. 11, 12 Hospitals have generally improved their perfor mance with these process-of-care measures, which are distinct from outcome measures that indicate how the health status of patients has changed. But whether such programs have con ferred clinically meaningful improvements in patient outcomes is debatable. [13] [14] [15] [16] [17] Regional Collaborations Regional collabo rations between hospitals and physicians may be more effective than either selective referral or pay-for-performance in improving the quality of health care at the population level. Pioneered by the Northern New England Cardiovascular Disease Study Group, regional collaborative im provement programs are based upon clinical registries containing detailed information about patients' risk status, processes of care, and out comes. 18 Hospitals and physicians receive regu lar and (usually) confidential feedback on their performance from their registry coordinating center-for example, risk-adjusted mortality rates for cardiac surgery. Hospital officials and physicians convene regularly to review and in terpret their data, often focusing on areas of variation in practice or outcomes. Best practices are then identified and implemented across the region, which may be an area within a large state or a group of one or more states.
Despite the conceptual appeal of this model and its success in northern New England, it has not been widely adopted in other parts of the United States. However, an ambitious pro gram in Michigan now provides the first oppor tunity to assess the value and practicality of regional collaborative improvement programs on a much larger scale.
After early success with a program focusing on percutaneous coronary interventions-com monly known as heart angioplasties-Blue Cross and Blue Shield of Michigan/Blue Care Network decided to make regional collaborative improve ment a major component of its statewide Value Partnership program. Then, in 2004, the insurer began implementing similar programs in other clinical areas. 19, 20 This insurer currently invests almost $30 million annually in nine programs, which collectively focus on the care of almost 200,000 Michigan patients annually.
Five of the programs-in breast cancer, cardiac computed tomography, peripheral vascular in terventions, trauma care, and hospital-based medical care-have not been established long enough to enable the judging of results. How ever, results from the other four, more mature regional collaborative improvement programstargeting percutaneous coronary interventions, cardiac surgery, bariatric surgery for obesity, and other types of general and vascular surgery-are now emerging.
Focus On Michigan We review the Michigan regional collaborative improvement program and its success to date in improving clinical out comes. Given the substantial cost of these im provement programs, we also consider savings accrued to payers as a result of fewer adverse outcomes or other efficiency gains and thus the return on investment from the payer perspec tive. Finally, we review lessons learned from the first five years of the Michigan program and po tential challenges associated with scaling up this model nationwide.
Overview Of The Program
Participants Blue Cross and Blue Shield of Michigan/Blue Care Network is the dominant private insurer in Michigan, insuring approxi mately 47 percent of the ten million residents of the state. Based on the assessment of the lead author of this article, David Share, approxi mately 5 percent of its total reimbursements to hospitals ($160 million annually) are currently reserved for its Participating Hospital Agree ment Incentive Program. This program includes elements of traditional pay-for-performance plans. However, 20 percent of the program's overall budget is devoted to nine regional col laborative improvement programs, whose an nual costs range from $1.2 million to more than $5 million each, according to financial docu ments from fiscal year 2010.
Each regional collaborative improvement pro gram is administered by a coordinating center staffed by one of the participating hospitals (mostly university-based), not by Blue Cross and Blue Shield of Michigan/Blue Care Network. Although staff composition varies by program, most coordinating centers have a physiciandirector, program epidemiologist or statistician, data analyst, data auditor, quality improvement nurse, and administrative support.
Costs And Payments Based on financial re ports from fiscal year 2010, payments to hospi tals account for most of the costs of the regional collaborative improvement programs. Hospitals are compensated for each improvement program in which they participate, regardless of their per formance relative to other centers. Payment for mulas were originally designed to cover the di rect costs of participation, but they are now based on a fixed percentage of each hospital's total payments from Blue Cross and Blue Shield of Michigan/Blue Care Network. In 2007 these payments to hospitals ranged from $11,000 to more than $1 million across the forty-four hos pitals participating in at least one regional col laborative improvement program.
For most hospitals, payments exceed the true costs of participation, according to a financial analysis conducted by John Birkmeyer, one of this paper's authors. Participating hospitals are expected to collect and submit data to the pro gram registries on a timely basis and allow regu lar site visits from data auditors. To receive pay ments, hospitals must send at least one physician-representative and a program co ordinator to the quarterly meetings of each regional collaborative improvement program and participate actively in statewide and hospi tal-specific quality improvement interventions.
Targeted Conditions The improvement pro grams target clinical conditions and procedures that are relatively common and that are associ ated with high costs per episode. They also tend to focus on procedures that are technically com plex, evolving rapidly, and associated with wide variation in hospital practice and outcomes.
Although the programs all administer detailed clinical registries, they vary in several aspects of data collection and measurement (Exhibit 1). Outcomes are measured using established na tional registries administered by professional organizations, locally developed databases, or some combination of the two.
Data To help hospitals target and monitor 
Clinical Improvements
The regional collaborative improvement pro grams vary widely with respect to their primary outcome measures, risk-adjustment models and statistical techniques, and use of external bench marks for assessing comparative improvements. In general, however, the success of the programs is judged by trends in statewide rates of use and adverse outcomes, which are assessed for both clinical and statistical significance. The latter is determined by regression-based time-series analyses, which adjust for any measurable changes in patient characteristics over time.
General And Vascular Surgery The largest of the regional collaborative improvement pro grams is the Michigan Surgical Quality Collabo rative, which targets general and vascular sur gery. Given the broad range of procedures included in this program, it tends to focus its quality improvement efforts on aspects of peri operative care-care before, during, and after surgery that is common to almost any type of inpatient surgery, including practices aimed at preventing common complications such as sur- In 2008-09, however, the public-use file no longer contained hospital identifiers. For this reason, we identified patients outside of Michi gan by using a matching algorithm based on patient characteristics, primary procedure code, and other variables. This algorithm matched more than 95 percent of patients.
When comparing the performance of hospitals in and outside of Michigan, we focused on thirtyday morbidity rates, which is the primary out come measure of the National Surgical Quality Improvement Program. To ensure fair compar isons between the two groups, morbidity rates were adjusted for patients' risk factors, including preoperative albumin, creatinine, functional sta tus, sepsis, inpatient and emergency surgery sta tus, illness severity (using the American Society of Anesthesiologists score), work relative value units, and surgical specialty (peripheral vascular versus general surgery).
In addition to cross-sectional comparisons, we used logistic regression to assess time trends in morbidity rates in both groups of hospitals after adjusting for the above covariates. Relative im provements in outcomes between the Michigan hospitals and the others were formally compared Cardiac Surgery For coronary artery bypass graft surgery, the regional collaborative im provement program rates hospital performance in terms of an eleven-item composite quality measure, which includes risk-adjusted mortal ity; complications; use of a section of the internal mammary artery that serves the chest wall and breasts as a graft; and several other important processes of care, as defined by the Adult Cardiac Surgery Registry of the Society of Thoracic Sur geons. 22 The Society of Thoracic Surgeons coor dinating center conducts most of the analyses for the Michigan program and provides it with regu lar reports on hospital-specific and statewide 
Return On Investment
The most persuasive return-on-investment analysis of the regional collaborative improve ment programs would require linking the clini cal outcome registries to claims databases and demonstrating the extent to which measured improvements lead directly to less cost to insur ers. Although this work is ongoing, there is rea son to believe that the programs more than pay for themselves.
For example, in general and vascular surgery alone, the approximately 2.5 percent drop in surgical morbidity rates observed by the Michi gan Surgical Quality Collaborative translates to 2,500 fewer Michigan patients with surgical complications each year, based on our analyses. One study-which used resource-based cost ac counting methods-found that the average cost of such complications is $11,000, of which 75 per cent is passed along to insurers. 5 If these esti mates are correct, the Michigan Surgical Quality Collaborative reduces payments associated with adverse outcomes by approximately $20 million annually-far exceeding the $5 million annual cost of administering the program.
The business case for the regional collabora tive improvement programs can be made with far less extrapolation. For example, in 2007 almost 10 percent of patients in Michigan hospitals undergoing gastric bypass surgery received inferior vena cava filters to prevent postopera tive pulmonary embolism. In this procedure, a filter is placed in the large abdominal vein that returns blood to the heart, in order to trap clot fragments and prevent them from traveling through the vein to the heart and lungs and caus ing blockage of circulation.
The use of these filters varied widely across hospitals, from 0 percent to more than 40 per cent. 23 Six of the twenty-four hospitals were plac ing the large majority of the filters being placed statewide. Analysis of outcome data from the Michigan Bariatric Surgery Collaborative re vealed that the use of inferior vena cava filters was not protective, but instead was associated with markedly higher risks of serious complica tions, many of which were directly related to complications from the filter itself. Following feedback of this information to surgeons and implementation of statewide guidelines, the use of the filters dropped to fewer than 2 percent of patients in a one-year period, according to Michigan Bariatric Surgery Collaborative data.
The average payment associated with placing the filter is $13,000 (in 2007 dollars), so this single change in practice saves payers more than $4 million annually-considerably more than the cost of administering the regional collaborative improvement program in bariatric surgery.
Several other specific quality improvement in terventions have also generated substantial sav ings. The use of two very expensive therapies in cardiac surgery-intra-aortic balloon pumps and prolonged mechanical ventilation-has fallen substantially. 22, 24 Implementation of risk-predic tion tools and practice guidelines has reduced the incidence of contrast-induced nephropathy (acute kidney failure triggered by the use of con trast dye in the procedure) and the need for dialysis after percutaneous coronary interven tion. 21 Between 2007 and 2009, rates of thirtyday emergency department visits after bariatric surgery fell from 8 percent to 5 percent, with associated savings approaching $1 million an nually.
Lessons Learned And Challenges For Dissemination
Hospitals have options for improving quality and efficiency that do not require them to col laborate with competing hospitals and physi cians. Internal quality improvement activities can include the implementation of protocols and clinical pathways that reduce unwanted variation and incorporate evidence-based prac tices and guidelines. Hospitals can also establish checklists to minimize mistakes and improve communication and teamwork among providers and staff. 25, 26 Unfortunately, although protocols and check lists help ensure that processes known to be ef fective (for example, timely administration of perioperative antibiotics) are implemented, such evidence-based practices represent only a small proportion of the overall care delivered to hospitalized patients. Such efforts do not teach hospitals and physicians how to improve other aspects of care.
Benefits Of Regional Collaboration Re sults from the Michigan initiative suggest that hospitals participating in regional collaborative improvement programs improve far more quickly than they can on their own. Practice variation across hospitals and surgeons creates innumerable "natural experiments" for identify ing what works and what doesn't.
The large sample sizes and statistical power associated with regional collaborative improve ment program registries allow for more robust, rapid assessment of relationships between proc ess and outcomes and of the effects of quality improvement interventions than can be achieved by hospitals examining their own prac
The insurer had the confidence that benefits would accrue primarily to its beneficiaries and purchasers.
tice in isolation. Although identification and im plementation of best practices are cornerstones of the regional collaborative improvement model, we believe that these programs also have salutary but immeasurable effects on the local safety culture. In our experience, participating hospitals and physicians simply start paying more attention to their practices and how to improve them.
Differences Among Programs It is difficult to identify which specific components of the regional collaborative improvement model are most important. Each program involves numer ous, concurrent interventions including perfor mance feedback, site visits, collaborative learn ing, and targeted interventions aimed at specific clinical problems. Their cumulative effects are not readily disentangled.
The programs also use different approaches to identifying and disseminating best practices. Some are more evidence based than others, rely ing primarily on empirical analyses that link specific processes of care to clinical outcomes data. Others place a greater emphasis on hospital site visits and benchmarking, examining organi zational factors and safety culture as well as spe cific processes of care. The comparative effective ness of these different strategies is difficult to assess.
We believe that improvements in Michigan hospitals are largely attributable to the programs themselves, not to trends toward improvement occurring everywhere. First, many of the im provements in overall outcome measures can be directly attributed to specific interventions initiated by the programs. For example, our analysis indicates that mortality rates associated with bariatric surgery fell in large part because of declining rates of fatal pulmonary embolism, which were temporally related to statewide im plementation of a protocol for increased preven tion of this complication. Similar examples in clude the effects of comprehensive interventions targeting surgical site infection in the Michigan Surgical Quality Collaborative and contrastrelated nephropathy in percutaneous coronary intervention.
Second, as described earlier, Michigan hospi tals had more substantial improvements in rates of morbidity and mortality than other hospitals participating in national data feedback pro grams administered by the Society of Thoracic Surgeons and the American College of Surgeons. Such data suggest that results in Michigan can not be attributed simply to secular trends toward improving technical quality. Because most of the regional collaborative improvement programs are based on clinically detailed, well-validated national outcomes registries, results in Michi gan cannot be attributed to differences in data collection techniques or outcomes definitions.
It is also important to note that hospitals par ticipating in the Adult Cardiac Surgery Registry of the Society of Thoracic Surgeons or the Ameri can College of Surgeons National Surgical Qual ity Improvement Program may represent a "high bar" for purposes of benchmarking. These pro grams are voluntary and may attract hospitals most committed to quality improvement. At least with the National Surgical Quality Improvement Program, large teaching centers are overrepre sented among participating hospitals and, based on our own (unpublished) analyses of national Medicare data, have notably lower surgical mor tality rates than nonparticipating US hospitals.
As currently implemented, the Michigan regional collaborative improvement programs are evaluated for their effect on cost and out comes in specific, clinically defined patient pop ulations, not for their cumulative effect on the health of the entire population. Nonetheless, be cause these programs target clinical conditions and procedures that are common, expensive, and associated with substantial morbidity, we believe that their benefits at the population level would compare favorably to weaker interven tions aimed at much broader populations, such as employee wellness programs and other pre ventive strategies.
Role Of Dominant Insurer Although suc cessful regional collaborative improvement pro grams do not necessarily require payer involve ment, the programs in Michigan would not have occurred had the state's largest private insurer not underwritten their substantial costs, offered additional financial incentives for hospitals to participate, and provided a neutral meeting ground for collaborating hospitals and physi cians. Although large private insurers are ob vious candidates for leading the dissemination of regional collaborative improvement programs nationwide, this model has challenges.
Given its dominant share of the private insur ance market in Michigan, Blue Cross and Blue Shield of Michigan/Blue Care Network had the leverage to urge hospitals to participate in the programs and the confidence that benefits would accrue primarily to its beneficiaries and purchas ers. Other states are similarly dominated by one large insurer; 27 several, including Tennessee and Florida, are implementing similar regional col laborative improvement programs. Although private insurers have taken the lead so far, regional collaborative improvement programs could be similarly fostered by public payers or regional coalitions of private payers, purchasers, and provider systems.
Relevance For National Efforts Evidence that regional collaborative improvement pro grams can simultaneously improve quality and reduce costs at the population level comes at an opportune time. The regional collaborative im provement model is particularly relevant to the interests of the Centers for Medicare and Medic aid Services as it begins to enact provisions of the Affordable Care Act, including accountable care organizations. 28 In that context, such programs provide a robust data infrastructure for monitor ing quality as health systems work toward con straining their costs.
More important, such programs provide a framework for facilitating improvement with re gard to both cost and quality domains. Regional collaborative improvement programs should also become increasingly attractive to hospitals and physicians as they seek to improve quality and reduce costs. 
Main Outcome Measure Complications occurring within 30 days of surgery.
Results Overall, 7.3% of patients experienced perioperative complications, most of which were wound problems and other minor complications. Serious complications were most common after gastric bypass (3.6%; 95% confidence interval [CI], 3.2%-4.0%), followed by sleeve gastrectomy (2.2%; 95% CI, 1.2%-3.2%), and laparoscopic adjustable gastric band (0.9%; 95% CI, 0.6%-1.1%) procedures (P<.001). Mortality occurred in 0.04% (95% CI, 0.001%-0.13%) of laparoscopic adjustable gastric band, 0 sleeve gastrectomy, and 0.14% (95% CI, 0.08%-0.25%) of the gastric bypass patients. After adjustment for patient characteristics and procedure mix, rates of serious complications varied from 1.6% (95% CI, 1.3-2.0) to 3.5% (95% CI, 2.4-5.0) (risk difference, 1.9; 95% CI, 0.08-3.7) across hospitals. Average annual procedure volume was inversely associated with rates of seri ous complications at both the hospital level (<150 cases, 4.1%; 95% CI, 3.0%-5.1%; 150 299 cases, 2.7%; 95% CI, 2.2-3.2; and :300 cases, 2.3%; 95% CI, 2.0%-2.6%; P=.003) and surgeon level (<100 cases, 3.8%; 95% CI, 3.2%-4.5%; 100-249 cases, 2.4%; 95% CI, 2.1%-2.8%;:250 cases, 1.9%; 95% CI, 1.4%-2.3%; P=.001). Adjusted rates of se rious complications were similar in COE and non-COE hospitals (COE, 2.7%; 95% CI, 2.5% 3.1%; non-COE, 2.0%; 95% CI, 1.5%-2.4%; P=.41).
Conclusions
The frequency of serious complications among patients undergoing bar iatric surgery in Michigan was relatively low. Rates of serious complications are in versely associated with hospital and surgeon procedure volume, but unrelated to COE accreditation by professional organizations. Whether COE accreditation helps pa tients and payers identify safer hospi tals for bariatric surgery remains a matter of debate. Hospital procedure volume, a core component of accredi tation, has been linked to periopera tive mortality with bariatric surgery. [3] [4] [5] [6] [7] [8] However, many of these studies are out dated. As bariatric surgery has been more commonplace and mortality has declined, previous hospital volume benchmarks (125 per year for COEs) may be less important now than in the past. To date, only 1 published study has directly compared the outcomes of bariatric surgery at COE and non-COE hospitals, noting higher mortal ity and equivalent morbidity at the former. 6 Because this study was based on administrative data, however, its re liability in capturing hospital compli cation rates is questionable. It also in cluded data from only 1 year, 2005, when COE programs were just begin ning to be implemented.
In this context, we studied periopera tive outcomes at 25 hospitals par ticipating in the Michigan Bariatric Surgery Collaborative (MBSC), a payerfunded quality improvement program that administers a prospective, exter nally audited clinical outcomes regis try. In addition to comparing compli cation rates by procedure and among hospitals, we examined relationships between procedure volume, COE ac creditation, and hospital safety.
METHODS

Study Sample
This study is based on analysis of data from the MBSC. As described in greater detail elsewhere, the MBSC is a re gional consortium of hospitals and sur geons performing bariatric surgery in Michigan. 9, 10 Participation in the MBSC is voluntary and any hospital that performs a minimum of 25 bariatric procedures per year is eligible to participate. The MBSC now enrolls ap proximately 6000 patients per year from 25 hospitals in its clinical registry. Par ticipating hospitals submit data for all of their bariatric surgery patients in cluding those undergoing gastric by pass, laparoscopic gastric banding, bil iopancreatic diversion with or without duodenal switch, and sleeve gastrec tomy procedures. Procedures done on an outpatient basis are included in the MBSC registry and are subject to the same data collection requirements.
In the MBSC, data for the clinical reg istry is collected via medical record re view for each patient at the end of the 30-day perioperative period. Informa tion collected includes demographic variables, preoperative clinical charac teristics and conditions, as well as peri operative process of care and out comes. Patient readmissions to other hospitals are captured if it is recorded in the medical records of the hospital performing the bariatric surgery. The medical record reviews are performed by centrally trained nurse data abstrac tors using a standardized and vali dated instrument. Each participating hospital is visited annually by the project data quality coordinator to verify the accuracy and completeness of its MBSC clinical registry data. The col lection of data for the purposes of par ticipation in the MBSC has been ap proved by the institutional review boards of all member sites.
For this study, we identified all pa tients undergoing bariatric surgery be tween June 2006 and September 2009, which includes 15 275 patients from 25 hospitals. We excluded patients under going revisional surgery from this analy sis because of the heterogeneity of the patient population and surgical proce dures as well as inherently higher rates of complications for patients undergo ing revisional surgery. We also ex cluded patients undergoing duodenal switch (n=245) for confidentiality rea sons since most of these procedures were performed by 1 surgeon in the state. We combined patients undergo ing open and laparoscopic gastric by pass procedures as there was no differ ence in the rates of major complications with the 2 procedures following ad justment for patient case mix and be cause open gastric bypass is now per formed so rarely (<5% of patients during the study period).
Outcomes
Data were collected on 12 different types of bariatric surgery-related complica tions. Complications were grouped according to severity as non-life threatening, potentially life-threaten ing, or life-threatening complications as sociated with residual and permanent disability or death. Potentially lifethreatening complications included ab dominal abscess (requiring percutane ous drainage or reoperation), bowel obstruction (requiring reoperation), leak (requiring percutaneous drainage or reoperation), bleeding (requiring trans fusion >4 units, endoscopy, reopera tion, or splenectomy), respiratory failure (requiring 2-7 days intubation), renal failure (requiring dialysis while patient is hospitalized during the perioperative period), wound infection/dehiscence (re quiring reoperation), and venous throm boembolism (deep vein thrombosis or pulmonary embolism). Complications resulting in permanent disability included myocardial infarction or car diac arrest, renal failure requiring longterm dialysis, respiratory failure requir ing more than 7 days of intubation, or tracheostomy. The MBSC end points committee grades the severity of any perioperative complications not falling unambiguously into one of these cat egories. Our primary outcome mea sure for this study was the occurrence of a serious complication defined as po tentially life threatening or resulting in death or disability.
Independent Variables
Data on patient characteristics include patient demographics, weight and medi cal history, and weight-related and other comorbidities listed in TABLE 1. In gen eral, MBSC comorbidity definitions in clude clinical documentation of the con dition, its treatment, or both in the medical record. Lung disease includes asthma, other obstructive/restrictive lung disease, and home oxygen use. Cardio vascular disease includes coronary ar tery disease, heart rhythm disorder, con gestive heart failure, or peripheral vascular disease. Patients with nonalco holic fatty liver, clinical or subclinical cir rhosis, or liver transplant are consid ered to have liver disorders.
Annual hospital and surgeon volume categories (TABLE 2) were determined usingacombinationofgenerallyaccepted volume cut points and empirical deriva tion based on the distribution of patients, hospitals,andsurgeons.Sitesweredeemed centers of excellence if they were desig nated as such by the American College of SurgeonsortheAmericanSocietyofMeta bolic and Bariatric Surgeons at any point during our study period. Two sites held BlueCrossandBlueShieldCentersofDis tinction status, which has similar crite ria to the other COE accreditation pro grams in addition to COE accreditation from the American College of Surgeons orAmericanSocietyofMetabolicandBar iatric Surgeons. tion rate at each hospital or for each surgeon toward the overall average, de pending on its reliability. Reliability is measured on a scale of 0 (completely un reliable) to 1 (perfectly reliable) and is largely a function of sample size. For this analysis, we used the random effects from the mixed-effects models to calculate risk-and reliability-adjusted complica tions rates for each hospital. For this cal culation, we add the overall average log (odds) of serious complications to the random effect (since the mean is 0 by definition) and then take the inverse logit of this sum. All reported P values are 2-sided, and P<.05 was considered sta tistically significant. All statistical analy ses were performed using Stata version 10.1 (StataCorp, College Station, Texas).
RESULTS
Patient Characteristics
There were significant differences across the procedure types with regard to all potential risk factors for complica tions, including demographics, medi cal history, and obesity-related comor bidity (Table 1) . In general, patients receiving laparoscopic adjustable gas tric bands were lower risk than pa tients receiving gastric bypass or sleeve gastrectomy. Specifically, patients re ceiving laparoscopic adjustable gas tric bands had significantly lower body mass index at baseline and lower rates of associated comorbid conditions. The predicted risk of serious complica tions based on a logistic regression model including significant multivar- tors that were significant in multivariate analyses(age,bodymassindex[calculated as weight in kilograms divided by height in meters squared], male sex, mobility limitations,priorhistoryofvenousthrom boembolism, and total number of comor bid conditions) and procedure type (lapa roscopic adjustable gastric band, sleeve gastrectomy, or gastric bypass) as fixed effects,andhospitalidentifierasarandom effect to adjust for clustering of patients within hospitals. Because hospital and surgeon com plication rates can vary due to chance alone, we adjusted our estimates for re liability. This technique adjusts hospi tal and surgeon outcomes for random variation, ensuring that performance is not overestimated or underestimated due to statistical noise. 11 Empirical Bayes methods shrink the observed complica- Complications at the surgical site oc curred in 5.9% of patients (95% CI, 5.6% 6.3%) and were highest in patients un dergoing gastric bypass (8.7%; 95% CI, 8.1%-9.3%), followed by patients receiv ing sleeve gastrectomy (3.6%; 95% CI, 2.5%-5.1%), and laparoscopic adjustable gastric band (1.7%; 1.4%-2.1%). Infec tion was the most frequent type of com plication (3.2%; 95% CI, 2.9%-3.5%) and was most common among patients un dergoing gastric bypass (4.4%; 95% CI, 4.0%-4.8%) and sleeve gastrectomy (2.5%; 95% CI, 1.5%-3.7%) procedures (Table 3 ). The subcategory of medical complications (including venous throm boembolism, cardiac, renal failure, and respiratory) occurred in 1.5% of patients overall (95% CI, 1.3%-1.7%), with the incidence varying from 0.58% (95% CI, 0.39%-0.82%) in patients with laparo scopic adjustable gastric band to 2.1% (95% CI, 1.8%-2.4%) in patients who re ceived gastric bypass.
Statistical Analyses
Rates of reoperation ranged from 0.59% (95% CI, 0.19%-1.4%) for sleeve gastrectomy to 2.5% (95% CI, 2.2% 2.8%) for gastric bypass procedures (Table 3 ). Transfers to other medical facilities (0.14%; 95% CI, 0.09% 0.22%) occurred infrequently. Hospi tal readmission and emergency depart ment visits occurred in 4% (95% CI, 3.7%-4.3%) and 6.8% (95% CI, 6.4% 7.2%) of patients overall, respectively. Rates of both readmission and emer gency department visits were lowest in patients who received laparoscopic ad justable gastric band and highest in those receiving gastric bypass. Me dian hospital length of stay (days) was 1 (range, 0-96), 2 (range, 0-63), and 2 (range, 0-148) for patients receiving laparoscopic adjustable gastric band, sleeve gastrectomy, and gastric by pass, respectively.
Variation in Serious Complication Rates
Risk-and reliability-adjusted rates of se rious complications varied from 1.6% (95% CI, 1.3%-2.0%) to 3.5% (95% CI, Risk of serious complications was in versely associated with average annual bariatric procedure volume (Table 2) . For surgeon volume, rates in the low-, medium-, and high-volume categories were 3.8% (95% CI, 3.2%-4.5%), 2.4% (95% CI, 2.1%-2.8%), and 1.9% (95% CI, 1.4%-2.3%), respectively (P for trend=.001). For hospital volume, ad- 2.8%-5.3%) for low-volume surgeons at low-volume hospitals than for highvolume surgeons at high-volume hospi tals (1.9%; 95% CI, 1.4%-2.3%). Over all, rates of serious complications were similar among patients undergoing sur gery at a COE (2.7%; 95% CI, 2.5% 3.1%) than for patients undergoing sur gery at non-COE hospitals (2.0%; 95% CI, 1.5%-2.4%). After adjustment for pa tient case and procedure mix, there re mained no significant difference in rates of serious complications at COE and non-COE hospitals (adjusted odds ra tio [OR], 1.27; 95% CI, 0.72-2.25; P=.41). There also was no significant dif ference (adjusted OR, 1.34; 95% CI, 0.88 2.05; P=.18) in rates of serious compli cations in the COE hospitals compared with the non-COE hospitals within hos pital procedure volume categories.
HOSPITAL COMPLICATION RATES WITH BARIATRIC SURGERY
2.4%-5.0%) by hospital (FIGURE). Rates
In our multivariate models, including patient risk and procedure mix reduced variation in serious complication rates acrosscentersby22%(TABLE4).Individu ally adding surgeon volume, hospital pro cedure volume, and COE status to this model reduced variation in serious com plicationratesacrosscentersby75%,59%, and 25%, respectively.
COMMENT
In this study, we report major peri operative adverse outcomes in a large cohort of bariatric surgery patients. Our results provide information about the perioperative risks of the various types of bariatric procedures in general prac tice. Overall, 7% of patients experi enced perioperative complications. The majority of complications were nonlife-threatening with minor wound problems being the most frequent type of complication. Approximately 2.5% of patients had more serious compli cations with mortality occurring in 0.12% of patients. Complication rates were highest for patients undergoing gastric bypass, followed by sleeve gas trectomy, and laparoscopic adjustable gastric band procedures.
Our study also suggests that the out comes of bariatric surgery reported from select academic centers are achievable more broadly. Rates of serious compli cations were similar across providers with rates between 2% and 3% for the majority of hospitals and surgeons. The results of our study are similar to those recently reported by a select group of high-volume bariatric programs par ticipating in the National Institutes of Health-funded Longitudinal Assess ment of Bariatric Surgery (LABS) Con sortium. 12 Despite similar patient popu lations, the overall rate of death and major complications are higher in LABS than those reported in our study. Higher complication rates reported in LABS may be attributable to the time peri ods studied, which included patients Similar to many high-risk surgical procedures, procedure volume has been shown to be an important pre dictor of adverse outcomes in bariat ric surgery. [3] [4] [5] [6] [7] [8] 13, 14 The results of our study are similar to what others have found regarding the magnitude of the procedure volume effect on morbidity with bariatric surgery. For example, a study based on discharge claims data from the state of Florida (1999 Florida ( -2003 found approximate 2-fold differences in adjusted rates of serious complica tions comparing the lowest to the highest volume strata for both hospi tals and surgeons. 7 A limitation of studies based on discharge claims databases is their ability to reliably capture nonfatal complications. Most of these prior volume outcome analy ses in bariatric surgery are also quite dated with the most recent cohort including patients from 2005. 6 Our results support those recently re ported by Livingston 6 that COE ac creditation is not associated with lower rates of bariatric complications. The prior study used 2005 National Inpa tient Survey data to compare morbid ity and mortality rates among 19 363 bariatric surgery patients at 24 COE and 229 non-COE centers. Mortality rates were higher at COE centers (0.17%) than non-COE centers (0.09%) and morbidity rates were close to identical (6.3% COE vs 6.4% non-COE). ORs ad justed for procedure volume, patient risk, and teaching status were 1.76 (P=.71) and 1.00 (P=.97) for mortality and morbidity, respectively. The study by Livingston 6 differed from ours in that it was based on claims data that cap tured only in-hospital complications and also included data from only 1 year (2005) when COE programs were just beginning to be implemented. [15] [16] [17] There are a number of reasons why COE accreditation by professional orga nizations or payers might not necessar ily identify safer hospitals with bariatric surgery.First,althoughCOEapplications oftenaskhospitalsforratesofspecificout comes (eg, postoperative venous throm boembolism), such outcomes data are generallynotauditedforaccuracyorcom pleteness and are often loosely defined. Second, aside from minimum caseloads, most requirements for bariatric COE ac creditation, including the availability of specific protocols and resources for man aging morbidly obese patients, are eas ily met by most hospitals with bariatric programs and likely have little bearing on surgical complication rates. Finally, given the highly competitive marketplace for bariatric surgery, COE accreditation programs may be attracting hospitals mo tivated as much by marketing advantage as by the desire to demonstrate and im prove their quality.
This study has numerous limitations. First, because all but 8 of the 25 hospi tals were COE-accredited by the end of the study period, we had suboptimal sta tistical power for detecting differences in risk between COE and non-COE hospi tals. Based on an level of .05, our study had only 70% power to detect a relative risk reduction of 25% or more associated with COE accreditation.
Second, we counted as COEs any hospital that had received that desig nation by the end of the study period. In sensitivity analysis, however, we as sessed the outcomes of patients accord ing to whether their hospitals were COEs at the time of their procedures. As in our main analysis, there was no significant difference in rates of seri ous complications between COE and non-COE hospitals (adjusted OR, 1.15; 95% CI, 0.92-1.43; P= .22).
When considering undergoing bar iatric surgery, patients should weigh the risks and benefits of the various treat ment options. Although we cannot yet report on the relative effectiveness of dif ferent bariatric procedures, prior stud ies suggest that weight loss is greater with procedures that combine both re strictive and malabsorptive elements than in purely restrictive procedures such as the laparoscopic adjustable gas tric band. [18] [19] [20] [21] [22] [23] [24] In the future, our study will be able to provide information regard ing the relative effectiveness of these dif ferent procedures with regard to weight loss, weight-related comorbidity reso lution, late complications, quality of life, patient satisfaction, and health care re source utilization.
Our study findings may not be gen eralizable outside of the state of Michi gan. These results reflect the out comes among bariatric surgery centers that participate in a statewide collabo rative quality improvement initiative. The extent to which this program, still in its first few years of existence, ex plains the relatively low rates of seri ous complications among bariatric hos pitals and surgeons in the state is unknown. However, these efforts go be yond data feedback, requiring the ac tive participation of bariatric surgeons in quality improvement initiatives and mandatory attendance at collabora tive meetings held 3 times each year. For this reason, we believe that the re sults reported in this study represent the outcomes of bariatric surgery that are possible, but not necessarily those that are typical in community settings.
In conclusion, the frequency of se rious complications among patients af ter bariatric surgery in Michigan is low. Rates of serious complications are in versely associated with hospital and sur geon procedure volume but not COE status. These data may serve as useful safety performance benchmarks for hos pitals performing bariatric surgery. We hope that they might also inform the debate about the effectiveness of vari ous approaches to ensuring highquality care for bariatric surgery pa tients.
